Huiyu Pharmaceutical(SH:688553) Sou Hu Cai Jing·2025-08-11 11:57Group 1 - The core viewpoint of the news is that Sichuan Huiyu Pharmaceutical Co., Ltd. has experienced a decline in revenue and net profit in its latest quarterly report, indicating potential challenges in its financial performance [1][3]. - As of August 11, 2025, the stock price of Huiyu Pharmaceutical was 22.49 yuan, with a slight increase of 0.94% and a trading volume of 68,700 hands, amounting to a transaction value of 153 million yuan [1]. - The company reported total revenue of 239 million yuan for the first quarter of 2025, a year-on-year decrease of 1.46%, and a net profit attributable to shareholders of 25.63 million yuan, down 155.19% year-on-year [1]. Group 2 - The company has a current ratio of 3.409, a quick ratio of 3.189, and a debt-to-asset ratio of 20.27%, indicating a strong liquidity position [1]. - Sichuan Huiyu Pharmaceutical has made investments in 13 enterprises and participated in 697 bidding projects, showcasing its active engagement in the market [2]. - The company holds 373 trademark registrations and 136 patent applications, along with 109 administrative licenses, reflecting its commitment to intellectual property and regulatory compliance [2].